πŸ‡ΊπŸ‡Έ FDA

Intelligence Platform

Patents

Browse 429 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 10941402

Chemically modified single-stranded RNA-editing oligonucleotides

ProQR Therapeutics II B.V. Β· Granted Tue Mar 09 2021 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 04 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10913957

Genetically modified MSC and therapeutic methods

The Regents of the University of California Β· Granted Tue Feb 09 2021 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 04 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10905709

Modified antisense oligomers for exon inclusion in spinal muscular atrophy

Sarepta Therapeutics, Inc. Β· Granted Tue Feb 02 2021 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 28 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10881086

Genetically modified mouse whose genome comprises a humanized CD274 gene

REGENERON PHARMACEUTICALS, INC. Β· Granted Tue Jan 05 2021 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 31 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10875885

Ξ²-d-2β€²-deoxy-2β€²-Ξ±-fluoro-2β€²-Ξ²-c-substituted-2-modified-n6-substituted purine nucleotides f

Atea Pharmaceuticals, Inc. Β· Granted Tue Dec 29 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 24 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10870673

Ξ²-D-2β€²-deoxy-2β€²-Ξ±-fluoro-2β€²-Ξ²-C-substituted-2-modified-N6-substituted purine nucleotides f

Atea Pharmaceuticals, Inc. Β· Granted Tue Dec 22 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 17 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10870672

Ξ²-D-2β€²-deoxy-2β€²-Ξ±-fluoro-2β€²-Ξ²-C-substituted-2-modified-N6-substituted purine nucleotides f

Atea Pharmaceuticals, Inc. Β· Granted Tue Dec 22 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 17 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10864266

Modified lipopolysaccharide glycoform and method of use

THE TRUSTEES OF PRINCETON UNIVERSITY Β· Granted Tue Dec 15 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 10 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10858633

Method for producing foot-and-mouth disease virus (FMDV) viral proteins utilizing a modifi

The Government of the United States of America, as represented by the Secretary of Homeland Security Β· Granted Tue Dec 08 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 03 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10842743

Modified hyaluronic acid hydrogels and proteins for the time-controlled release of biologi

The Regents of the University of California Β· Granted Tue Nov 24 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 19 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10844098

Method for preparing bacterial polysaccharide-modified recombinant fusion protein and use

Institute of Biotechnology, Academy of Military Medical Sciences, China Β· Granted Tue Nov 24 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 19 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10835593

Modified anthrax toxin protective antigen

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Nov 17 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 12 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10815266

Ξ²-D-2β€²-deoxy-2β€²-Ξ±-fluoro-2β€²-Ξ²-C-substituted-2-modified-N6-substituted purine nucleotides f

Atea Pharmaceuticals, Inc. Β· Granted Tue Oct 27 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 22 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10808230

Selection methods for genetically-modified T cells

The Board of Regents of the University of Texas System Β· Granted Tue Oct 20 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 15 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10800833

Co-stimulatory domains for use in genetically-modified cells

Precision BioSciences, Inc. Β· Granted Tue Oct 13 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 08 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10785968

Genetically modified non-human animals and methods of use thereof

REGENERON PHARMACEUTICALS, INC. Β· Granted Tue Sep 29 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 24 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10781435

Modified membrane type serine protease 1 (MTSP-1) polypeptides and methods of use

Catalyst Biosciences, Inc. Β· Granted Tue Sep 22 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 17 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10760078

Oligonucleotide analogues having modified intersubunit linkages and/or terminal groups

Sarepta Therapeutics, Inc. Β· Granted Tue Sep 01 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 27 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10730837

Modified amino acids

Sutro Biopharma, Inc. Β· Granted Tue Aug 04 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 30 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10722459

Methods for producing carboxylate ligand modified ferric iron hydroxide colloids and relat

United Kingdom Research and Innovation Β· Granted Tue Jul 28 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 23 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10717720

Modified compound of andrographolide

Medshine Discovery Inc. Β· Granted Tue Jul 21 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 16 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10711257

Modified cascade ribonucleoproteins and uses thereof

Caribou Biosciences, Inc. Β· Granted Tue Jul 14 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 09 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10676740

Modified iRNA agents

Alnylam Pharmaceuticals, Inc. Β· Granted Tue Jun 09 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 04 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10668170

Modified RNAi agents

Alnylam Pharmaceuticals, Inc. Β· Granted Tue Jun 02 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 28 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted